Report overview
Immunoglobulin?s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen. These are made up of basic structural unit?s namely heavy chains and light chains. In mammals five different types of antibodies (IgA, IgD, IgE, IgG and IgM) are present which perform different role in response to the type of foreign antibody encountered. Occurrences of situations where people are born with low or no level of immunoglobulin, or with an immune system that does not function properly are very common. In such condition fighting with germs and other infections become extremely difficult. Therefore, immunoglobulin therapy plays an important role for compensating the insufficient quantity of immunoglobulin in the body.
This report aims to provide a comprehensive presentation of the global market for Immunoglobulin Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunoglobulin Products. This report contains market size and forecasts of Immunoglobulin Products in global, including the following market information:
Global Immunoglobulin Products Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Immunoglobulin Products Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Immunoglobulin Products companies in 2022 (%)
The global Immunoglobulin Products market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The recent approval of immunoglobulins to treat neuroimmunological disorders is a noteworthy factor that will impel the prospects for market growth until the end of the forecast period. Recently, immunoglobulin products were approved for the treatment of neuroimmunological disorders like multifocal motor neuropathy, Alzheimer's disease, and Guillain-Barr? syndrome. Due to its widespread applicability, immunoglobulin products that are utilized for the treatment of neuroimmunological disorders are anticipated to contribute the largest proportion of revenue to the global immunoglobulin products market in the next few years. Immunoglobulin products used for the treatment of primary immunodeficiency disease (PID) and neuroimmunological disorders account for around 80% of the total market revenue.
We surveyed the Immunoglobulin Products manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunoglobulin Products Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Immunoglobulin Products Market Segment Percentages, by Type, 2022 (%)
IG A
IG G
IG M
IG D
IG E
Global Immunoglobulin Products Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Immunoglobulin Products Market Segment Percentages, by Application, 2022 (%)
CIDP
Immunodeficiency Diseases
ITP
Hypogammaglobulinemia
Congenital AIDS
Multifocal Motor Neuropathy
CLL
Myasthenia Gravis
Kawasaki Disease
Global Immunoglobulin Products Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Immunoglobulin Products Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunoglobulin Products revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Immunoglobulin Products revenues share in global market, 2022 (%)
Key companies Immunoglobulin Products sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Immunoglobulin Products sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
China Biologic Products
Grifols
Biotest Pharmaceuticals
Bio Products Laboratory
Octapharma
CSL
Kedrion
Bharat Serums and Vaccines
Emergent Biosolutions
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immunoglobulin Products, market overview.
Chapter 2: Global Immunoglobulin Products market size in revenue and volume.
Chapter 3: Detailed analysis of Immunoglobulin Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immunoglobulin Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Immunoglobulin Products capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
